{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:27:39Z","timestamp":1767864459928,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13346-021-00899-5","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T22:02:33Z","timestamp":1611439353000},"page":"213-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pluronic F127-tailored lecithin organogel of acyclovir: preclinical evidence of antiviral activity using BALB\/c murine model of cutaneous HSV-1 infection"],"prefix":"10.1007","volume":"12","author":[{"given":"Gajanand","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimaldeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basant","family":"Amarji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mini P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-2065","authenticated-orcid":false,"given":"Om Prakash","family":"Katare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"899_CR1","first-page":"2501","volume-title":"Fields Virology","author":"B Roizman","year":"2007","unstructured":"Roizman B, Knipe DM, Whitley R. Herpes simplex viruses. In: Knipe DM, Howley P, editors. Fields Virology. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2007. p. 2501\u2013601."},{"key":"899_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Roizman B. Herpes simplex virus infections. The Lancet. 2001;357:1513\u20138.","journal-title":"The Lancet"},{"key":"899_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00325481.1983.11697814","volume":"73","author":"B Bean","year":"1983","unstructured":"Bean B. Acyclovir in the treatment of herpe svirus infections. Postgrad Med J. 1983;73:297\u2013303.","journal-title":"Postgrad Med J"},{"key":"899_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s13346-017-0417-0","volume":"7","author":"G Sharma","year":"2017","unstructured":"Sharma G, Thakur K, Setia A, Amarji B, Singh MP, Raza K, et al. Fabrication of acyclovir-loaded flexible membrane vesicles (FMVs): evidence of preclinical efficacy of antiviral activity in murine model of cutaneous HSV-1 infection. Drug Delivery and Translational Research. 2017;7:683\u201394.","journal-title":"Drug Delivery and Translational Research"},{"key":"899_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/21691401.2017.1313262","volume":"46","author":"A Kaur","year":"2018","unstructured":"Kaur A, Sharma G, Gupta V, Ratho RK, Katare OP. Enhanced acyclovir delivery using w\/o type microemulsion: preclinical assessment of antiviral activity using murine model of zosteriform cutaneous HSV-1 infection. Artif Cells Nanomed Biotechnol. 2018;46:346\u201354.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"899_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1517\/17425240802450340","volume":"5","author":"R Cortesi","year":"2008","unstructured":"Cortesi R, Esposito E. Acyclovir delivery systems. Expert Opin Drug Deliv. 2008;5:1217\u201330.","journal-title":"Expert Opin Drug Deliv"},{"key":"899_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1529-8019.2012.01464.x","volume":"24","author":"S Fireman","year":"2011","unstructured":"Fireman S, Toledano O, Neimann K, Loboda N, Dayan N. A look at emerging delivery systems for topical drug products. Dermatol Ther. 2011;24:477\u201388.","journal-title":"Dermatol Ther"},{"key":"899_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3851\/IMP2970","volume":"21","author":"AB Nair","year":"2016","unstructured":"Nair AB. Quantification of uptake and clearance of acyclovir in skin layers. Antivir Ther. 2016;21:17\u201325.","journal-title":"Antivir Ther"},{"key":"899_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1128\/AAC.29.5.730","volume":"29","author":"DJ Freeman","year":"1986","unstructured":"Freeman DJ, Sheth NV, Spruance SL. Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother. 1986;29:730\u20132.","journal-title":"Antimicrob Agents Chemother"},{"key":"899_CR10","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1208\/pt060240","volume":"6","author":"R Kumar","year":"2005","unstructured":"Kumar R, Katare OP. Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. AAPS PharmSciTech. 2005;6:E298\u2013310.","journal-title":"AAPS PharmSciTech"},{"key":"899_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s13346-017-0364-9","volume":"8","author":"G Sharma","year":"2018","unstructured":"Sharma G, Devi N, Thakur K, Jain A, Katare OP. Lanolin-based organogel of salicylic acid: evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB\/c mice model. Drug Deliv Transl Res. 2018;8:398\u2013413.","journal-title":"Drug Deliv Transl Res"},{"key":"899_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.18433\/J3HW2B","volume":"15","author":"H Almeida","year":"2012","unstructured":"Almeida H, Amaral MH, Lobao P, Lobo JM. Pluronic(R) F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs. J Pharm Pharm Sci. 2012;15:592\u2013605.","journal-title":"J Pharm Pharm Sci"},{"key":"899_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/10717540903508961","volume":"17","author":"M Pandey","year":"2010","unstructured":"Pandey M, Belgamwar V, Gattani S, Surana S, Tekade A. Pluronic lecithin organogel as a topical drug delivery system. Drug Deliv. 2010;17:38\u201347.","journal-title":"Drug Deliv"},{"key":"899_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.18433\/J3V89W","volume":"19","author":"H Alsaab","year":"2016","unstructured":"Alsaab H, Bonam SP, Bahl D, Chowdhury P, Alexander K, Boddu SH. Organogels in drug delivery: a special emphasis on pluronic lecithin organogels. J Pharm Pharm Sci. 2016;19:252\u201373.","journal-title":"J Pharm Pharm Sci"},{"key":"899_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0378-5173(99)00119-2","volume":"184","author":"JM Barichello","year":"1999","unstructured":"Barichello JM, Morishita M, Takayama K, Nagai T. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm. 1999;184:189\u201398.","journal-title":"Int J Pharm"},{"key":"899_CR16","doi-asserted-by":"publisher","unstructured":"Sharma\u00a0G, Devi\u00a0N,  Thakur\u00a0K,  Jain\u00a0A,  Katare\u00a0OP.  Lanolin-based organogel of salicylic acid: evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB\/c mice model. Drug Deliv Transl Res. 2017;\u00a0https:\/\/doi.org\/10.1007\/s13346-017-0364-9","DOI":"10.1007\/s13346-017-0364-9"},{"key":"899_CR17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1208\/s12249-015-0464-0","volume":"17","author":"G Sharma","year":"2016","unstructured":"Sharma G, Dhankar G, Thakur K, Raza K, Katare OP. Benzyl benzoate-loaded microemulsion for topical applications: enhanced dermatokinetic profile and better delivery promises. AAPS PharmSciTech. 2016;17:1221\u201331.","journal-title":"AAPS PharmSciTech"},{"key":"899_CR18","doi-asserted-by":"crossref","unstructured":"Yadav NK, Nanda S, Sharma G, Katare OP. Systematically optimized ketoprofen-loaded novel proniosomal formulation for periodontitis: in vitro characterization and in vivo pharmacodynamic evaluation. AAPS PharmSciTech. 2017;18:1863\u201380.","DOI":"10.1208\/s12249-016-0665-1"},{"key":"899_CR19","doi-asserted-by":"crossref","unstructured":"Chhibber T, Wadhwa S, Chadha P, Sharma G, Katare OP. Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. J Drug Target. 2015;1\u201310.","DOI":"10.3109\/1061186X.2015.1048518"},{"key":"899_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/1061186X.2015.1077845","volume":"24","author":"NK Yadav","year":"2016","unstructured":"Yadav NK, Nanda S, Sharma G, Katare OP. Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation. J Drug Target. 2016;24:257\u201371.","journal-title":"J Drug Target"},{"key":"899_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2013.01.029","volume":"444","author":"A Bhatia","year":"2013","unstructured":"Bhatia A, Singh B, Raza K, Wadhwa S, Katare OP. Tamoxifen-loaded lecithin organogel (LO) for topical application: development, optimization and characterization. Int J Pharm. 2013;444:47\u201359.","journal-title":"Int J Pharm"},{"key":"899_CR22","unstructured":"ICH. Q1A(R2) Stability testing of new drug substances and products, In: International Conference on Harmonisation, IFPMA, Geneva, 2003."},{"key":"899_CR23","doi-asserted-by":"publisher","first-page":"118977","DOI":"10.1016\/j.ijpharm.2019.118977","volume":"576","author":"K Thakur","year":"2020","unstructured":"Thakur K, Mahajan A, Sharma G, Singh B, Raza K, Chhibber S, et al. Implementation of Quality by Design (QbD) approach in development of silver sulphadiazine loaded egg oil organogel: an improved dermatokinetic profile and therapeutic efficacy in burn wounds. Int J Pharm. 2020;576:118977.","journal-title":"Int J Pharm"},{"key":"899_CR24","doi-asserted-by":"crossref","unstructured":"Heck R, Lukic MZ, Savic SD, Daniels R, Lunter DJ. Ex vivo skin permeation and penetration of nonivamide from and in vivo skin tolerability of film-forming formulations containing porous silica. Eur J Pharm Sci. 2017;106.","DOI":"10.1016\/j.ejps.2017.05.045"},{"key":"899_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/nnm-2016-0405","volume":"12","author":"G Sharma","year":"2017","unstructured":"Sharma G, Saini MK, Thakur K, Kapil N, Garg NK, Raza K, et al. Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study. Nanomedicine (Lond). 2017;12:615\u201338.","journal-title":"Nanomedicine (Lond)"},{"key":"899_CR26","doi-asserted-by":"publisher","first-page":"20713","DOI":"10.1039\/C5RA24516H","volume":"6","author":"G Sharma","year":"2016","unstructured":"Sharma G, Kaur M, Raza K, Thakur K, Katare OP. Aceclofenac\u2013\u03b2-cyclodextrin-vesicles: a dual carrier approach for skin with enhanced stability, efficacy and dermatokinetic profile. RSC Advances. 2016;6:20713\u201327.","journal-title":"RSC Advances"},{"key":"899_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0378-5173(03)00183-2","volume":"258","author":"DD Verma","year":"2003","unstructured":"Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258:141\u201351.","journal-title":"Int J Pharm"},{"key":"899_CR28","doi-asserted-by":"publisher","first-page":"71500","DOI":"10.1039\/C5RA11687B","volume":"5","author":"G Sharma","year":"2015","unstructured":"Sharma G, Beg S, Thanki K, Katare OP, Jain S, Kohli K, et al. Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance. RSC Advances. 2015;5:71500\u201313.","journal-title":"RSC Advances"},{"key":"899_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/21691401.2016.1161639","volume":"45","author":"K Rajpoot","year":"2017","unstructured":"Rajpoot K. Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization. Artif Cells Nanomed Biotechnol. 2017;45:551\u20139.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"899_CR30","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3109\/10717544.2016.1155244","volume":"23","author":"G Sharma","year":"2016","unstructured":"Sharma G, Goyal H, Thakur K, Raza K, Katare OP. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation. Drug Delivery. 2016;23:3135\u201345.","journal-title":"Drug Delivery"},{"key":"899_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0367-326X(00)00263-X","volume":"72","author":"MI Craig","year":"2001","unstructured":"Craig MI, Benencia F, Coulombie FC. Antiviral activity of an acidic polysaccharides fraction extracted from Cedrela tubiflora leaves. Fitoterapia. 2001;72:113\u20139.","journal-title":"Fitoterapia"},{"key":"899_CR32","doi-asserted-by":"publisher","first-page":"e104113","DOI":"10.1371\/journal.pone.0104113","volume":"9","author":"P Orlowski","year":"2014","unstructured":"Orlowski P, Tomaszewska E, Gniadek M, Baska P, Nowakowska J, Sokolowska J, et al. Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS ONE. 2014;9:e104113.","journal-title":"PLoS ONE"},{"key":"899_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1128\/jvi.52.3.816-821.1984","volume":"52","author":"A Simmons","year":"1984","unstructured":"Simmons A, Nash AA. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol. 1984;52:816\u201321.","journal-title":"J Virol"},{"key":"899_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0166-3542(99)00024-8","volume":"42","author":"S Iwayama","year":"1999","unstructured":"Iwayama S, Ohmura Y, Suzuki K, Ono N, Nakazawa H, Aoki M, et al. Evaluation of anti-herpesvirus activity of (1\u2019S,2\u2019R)-9-[[1\u2019,2\u2019-bis(hydroxymethyl)cycloprop-1\u2019-yl]methyl]guanine (A-5021) in mice. Antiviral Res. 1999;42:139\u201348.","journal-title":"Antiviral Res"},{"key":"899_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0166-3542(94)00076-K","volume":"27","author":"M Kurokawa","year":"1995","unstructured":"Kurokawa M, Nagasaka K, Hirabayashi T, Uyama S, Sato H, Kageyama T, et al. Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res. 1995;27:19\u201337.","journal-title":"Antiviral Res"},{"key":"899_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0166-3542(97)00049-1","volume":"36","author":"J Sheridan","year":"1997","unstructured":"Sheridan J, Kern E, Martin A, Booth A. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections. Antiviral Res. 1997;36:157\u201366.","journal-title":"Antiviral Res"},{"key":"899_CR37","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/AAC.45.4.1030-1036.2001","volume":"45","author":"J Piret","year":"2001","unstructured":"Piret J, Lamontagne J, Desormeaux A, Bergeron MG. Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1. Antimicrob Agents Chemother. 2001;45:1030\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"899_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.antiviral.2006.06.004","volume":"72","author":"S Rechter","year":"2006","unstructured":"Rechter S, Konig T, Auerochs S, Thulke S, Walter H, Dornenburg H, et al. Antiviral activity of Arthrospira-derived spirulan-like substances. Antiviral Res. 2006;72:197\u2013206.","journal-title":"Antiviral Res"},{"key":"899_CR39","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1086\/379043","volume":"188","author":"A Wald","year":"2003","unstructured":"Wald A, Huang M, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188:1345\u201351.","journal-title":"J Infect Dis"},{"key":"899_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1086\/598618","volume":"29","author":"DN Fredricks","year":"1999","unstructured":"Fredricks DN, Relman DA. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin Infect Dis. 1999;29:475\u201386.","journal-title":"Clin Infect Dis"},{"key":"899_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0885328206056312","volume":"21","author":"K Pal","year":"2006","unstructured":"Pal K, Banthia A, Majumdar D. Polyvinyl alcohol\u2014gelatin patches of salicylic acid: preparation, characterization and drug release studies. J Biomater Appl. 2006;21:75\u201391.","journal-title":"J Biomater Appl"},{"key":"899_CR42","first-page":"151","volume":"6","author":"S Nie","year":"2011","unstructured":"Nie S, Hsiao WL, Pan W, Yang Z. Thermoreversible Pluronic(\u00c2\u00ae) F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomedicine. 2011;6:151\u201366.","journal-title":"Int J Nanomedicine"},{"key":"899_CR43","doi-asserted-by":"crossref","unstructured":"Visalli RJ, Courtney Rj, Meyers C. Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology. 1997;230:236\u201343.","DOI":"10.1006\/viro.1997.8484"},{"key":"899_CR44","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1023\/B:PHAM.0000029277.60760.43","volume":"21","author":"CA Jarvis","year":"2004","unstructured":"Jarvis CA, McGuigan C, Heard CM. In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skin. Pharm Res. 2004;21:914\u20139.","journal-title":"Pharm Res"},{"key":"899_CR45","doi-asserted-by":"crossref","unstructured":"Hasler-Nguyen N, Shelton D, Ponard G, Bader M, Schaffrik M, Mallefet P. Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection. BMC Dermatol. 2009;9.","DOI":"10.1186\/1471-5945-9-3"},{"key":"899_CR46","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.colsurfb.2009.10.003","volume":"75","author":"GM El Maghraby","year":"2010","unstructured":"El Maghraby GM. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces. 2010;75:595\u2013600.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"899_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/mp500542a","volume":"12","author":"DV Nguyen","year":"2015","unstructured":"Nguyen DV, Li F, Li H, Wong BS, Low CY, Liu XY, et al. Drug permeation through skin is inversely correlated with carrier gel rigidity. Mol Pharm. 2015;12:444\u201352.","journal-title":"Mol Pharm"},{"key":"899_CR48","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/10717544.2014.933284","volume":"23","author":"A Hussain","year":"2016","unstructured":"Hussain A, Samad A, Singh SK, Ahsan MN, Haque MW, Faruk A, et al. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv. 2016;23:642\u20137.","journal-title":"Drug Deliv"},{"key":"899_CR49","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1086\/656717","volume":"202","author":"DC Quenelle","year":"2010","unstructured":"Quenelle DC, Lampert B, Collins DJ, Rice TL, Painter GR, Kern ER. Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies. J Infect Dis. 2010;202:1492\u20139.","journal-title":"J Infect Dis"},{"key":"899_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2004.02.028","volume":"97","author":"DD Verma","year":"2004","unstructured":"Verma DD, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J Control Release. 2004;97:55\u201366.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00899-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00899-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00899-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:33:02Z","timestamp":1666845182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00899-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00899-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"5 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The current study does not include any human subjects. The study protocols on animal experiments were duly approved by the Institutional Animal Ethics Committee (Ref. No. IAEC\/52-62), Panjab University, Chandigarh.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent of all authors\/co-authors has been taken, and all are aware of the progress of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}